EP4110292
LYFJASAMSETNING Á VÖKVAFORMI SEM INNIHELDUR ENSÍFENTRÍN OG GLÝKÓPYRRÓLAT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.2.2021EP published:
10.1.2024EP application number:
21709782.3
EP translation filed:
6.2.2024Grant published:
15.4.2024EPO information:
European Patent Register
Max expiry date:
25.2.2041Expiry date:
25.2.2027Next due date:
28.2.2027
Title in English:
LIQUID PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE AND GLYCOPYRROLATELanguage of the patent:
English
Timeline
Today
26.2.2021EP application
10.1.2024EP Publication
6.2.2024Translation submitted
15.4.2024Registration published
25.2.2027Expires
Owner
Name:
Verona Pharma PLCAddress:
One Central Square, Cardiff CF10 1FS, GB
Inventor
Name:
SPARGO, Peter LionelAddress:
Canterbury Kent CT2 8NR, GB
Name:
HAYWOOD, Phillip AndrewAddress:
Hertfordshire SG9 0DH, GB
Name:
FRENCH, Edward JamesAddress:
Canterbury Kent CT1 3LX, GB
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
202002786Date:
27.2.2020Country:
GB
Classification
Categories:
A61K 9/10, A61P 11/00, A61K 31/40, A61K 31/519, A61K 47/14
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 12.2.2024
Expires: 25.2.2025
Payer: Tego IP ehf.
Number: 5
Paid: 16.1.2025
Expires: 25.2.2026
Payer: Árnason Faktor ehf.
Number: 6
Paid: 16.2.2026
Expires: 25.2.2027
Payer: Árnason Faktor ehf.